BROADCASTS.com

In your clinical experience, you may have cared for patients receiving palliative chemotherapy and wondered, hmmm, why is that called \u201cpalliative\u201d chemotherapy? We\u2019ve written about this issue previously here at GeriPal (\u201ca term that should be laid to rest\u201d) as has Pallimed (\u201can oxymoron\u201d).

Well, now we have \u201cpalliative\u201d inotropes for people with heart failure.\xa0 And we have to ask, is this a fitting term?\xa0 And the answer is...complex...more so than you might think.\xa0 Recall that in one of our earliest podcasts, we talked with Nate Goldstein who memorably proclaimed \u201cthe best palliative care for heart failure is treatment for heart failure.\u201d\xa0\xa0

To unpack the issue of palliative inotropes, we welcome back Haider Warraich, a cardiologist with a strong interest in palliative care.\xa0 We are joined again by Anne Rohlfing, palliative care fellow at UCSF who spent last year as a hospitalist on the heart failure service.\xa0

Please tune in to hear more about the role of palliative care in inotrope therapy, inotropes in hospice, Haider\u2019s study on palliative needs of patients with heart failure, and a bit about Left Ventricular Assist Devices (including a shout out to Dan Matlock\u2019s decision aids) and Haider\u2019s Journal of Palliative Medicine paper on top 10 tips for palliative care clinicians on caring for patients with LVADs.

-@AlexSmithMD